Highlights GLP-1 medicines reduce fat and liver mass more rapidly than skeletal muscle (SKM) Running performance is maintained or improved in mice on GLP-1 medicine GLP-1 medicine modifies the SKM proteome despite similar weight loss as calorie restriction Patients on GLP-1 medicine slightly reduce SKM mass but largely maintain strength Summary The large decrease in body weight with glucagon-like peptide-1 (GLP-1) medicines raises concern about a loss of lean body mass (LBM) and skeletal muscle
[28] Your GP can arrange appropriate investigations including HbA1c, fasting glucose, and lipid profiles to assess your metabolic health and determine whether medical intervention is appropriate
Natural origin does not eliminate the possibility of adverse effects, interactions, or complications
The same stimulant effects that help with ADHDraising heart rate, boosting alertness, and increasing energycan also trigger anxious sensations
And that kind of muscle is very prone to wasting and sarcopenia
Clinical trials did not specify morning versus evening dosing